Remix Therapeutics

Senior Manager, SEC Reporting

Remix Therapeutics$157K — $192K *
Pharmaceuticals & Biotech
5 - 7 years of experience
Job Overview by Ladders

Qualifications

  • Bachelor's degree in accounting or finance
  • Active CPA license required
  • 5+ years of accounting and financial reporting experience
  • Big 4 public accounting experience
  • Experience in clinical-stage biotech or life sciences
  • Strong understanding of U.S. GAAP and SEC reporting
  • Excellent communication skills
  • Proven project management and organizational abilities

Responsibilities

  • Prepare and coordinate SEC filings, including Forms S-1, 10-Q, 10-K, and 8-K
  • Draft and review financial disclosures in compliance with U.S. GAAP
  • Support IPO readiness, including disclosure controls and SOX compliance
  • Collaborate with cross-functional teams to gather information for filings
  • Research technical accounting issues and draft memoranda
  • Coordinate reporting timelines for accurate and punctual filings
  • Assist with equity accounting and stock compensation reporting
  • Monitor new accounting standards and assess their impact
  • Drive process improvements for scalable reporting infrastructure

Benefits

  • Exposure to executive leadership
  • Professional growth opportunities
  • Impact on the organization's success
  • Dynamic and fast-paced work environment
Full Job Description
Position Summary:

The Senior Manager, SEC Reporting will play a critical role in supporting public company readiness initiatives and leading external financial reporting activities. Reporting to the Head of Finance, this individual will be responsible for preparing SEC filings, supporting technical accounting matters, and helping establish scalable reporting and compliance processes appropriate for a public company environment. The ideal candidate will bring strong technical accounting expertise, excellent project management capabilities, and the ability to work independently in a fast-paced clinical-stage biotech environment.

This is an exciting opportunity to join a growing clinical-stage biotechnology company at a transformational stage and help build the infrastructure of a future public company. The role offers meaningful exposure to executive leadership, opportunities for professional growth, and the ability to make a significant impact on the organization's future success.

Key Responsibilities:
  • Prepare and coordinate SEC filings, including Forms S-1, 10-Q, 10-K, 8-K, and related disclosures and supporting schedules
  • Draft and review footnote disclosures and MD&A in accordance with U.S. GAAP and SEC reporting requirements
  • Support IPO readiness activities, including implementation of disclosure controls and SOX compliance processes
  • Partner cross-functionally with FP&A, Legal, HR, Clinical Operations, and external auditors/advisors to gather and validate information for filings
  • Research technical accounting matters and prepare accounting memoranda
  • Coordinate reporting timelines and ensure timely and accurate filings
  • Support quarterly and annual close activities related to external reporting
  • Assist with equity accounting and stock compensation reporting
  • Monitor new accounting pronouncements and SEC regulations and assess their impact on the company
  • Drive process improvements and help build scalable reporting infrastructure as the organization grows

Personal Attributes:
  • Highly detail-oriented with strong analytical and problem-solving skills
  • Hands-on, proactive, and solutions-oriented mindset
  • Comfortable operating in a dynamic, fast-paced environment
  • Collaborative team player with strong interpersonal skills
  • Ability to maintain confidentiality and exercise sound judgment

Qualifications:

Required
  • Bachelor's degree in accounting or finance
  • Active CPA license required
  • Minimum 5+ years of progressive accounting and financial reporting experience
  • Big 4 public accounting experience
  • Clinical-stage biotechnology or life sciences industry experience
  • Strong understanding of U.S. GAAP and SEC reporting requirements
  • Strong written and verbal communication skills
  • Demonstrated ability to work independently and drive projects to completion with minimal supervision
  • Excellent project management and organizational skills with the ability to manage multiple priorities and deadlines

Preferred
  • Master's degree
  • Experience supporting IPO readiness and/or operating in a pre-public or newly public company environment
  • Advanced Excel skills and familiarity with reporting systems

Salary Range

$157,000.00 - $192,000.00 USD

This range reflects the expected base salary for this position, plus bonus, equity, and benefits as applicable. Actual salaries may vary based on factors, such as skill, experience, and qualification for the role.

About Remix Therapeutics

Remix Therapeutics is a biotechnology company that is developing small molecule therapies for genetic diseases. The company's approach is based on RNA splicing modulation, which involves targeting the splicing process that occurs during gene expression. By modulating RNA splicing, Remix Therapeutics aims to correct genetic mutations that cause diseases such as cystic fibrosis and Duchenne muscular dystrophy. The company was founded in 2020 and is based in Cambridge, Massachusetts.
Learn more about Remix Therapeutics
Size
10 employees
Industry
Founded
2020

Similar Jobs

More Jobs at Remix Therapeutics

More Pharmaceuticals & Biotech Jobs

Find similar Senior Manager, SEC Reporting jobs: